Intratympanic dexamethasone is an effective method as a salvage treatment in refractory sudden hearing loss

Otology and Neurotology

Volumn 32, Issue 9, 2011, Pages 1432-1436

  Moon, In Seok ^a   Lee, Jong Dae ^b   Kim, Jin ^c   Hong, Sung Jong ^a   Lee, Won Sang ^c  

^a Chung Ang University College of Medicine   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; AUDITORY THRESHOLD; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; EARDRUM; HUMAN; MIDDLE AGED; SALVAGE THERAPY; SUDDEN DEAFNESS; TREATMENT OUTCOME;

ADULT; AGED; AUDITORY THRESHOLD; DEXAMETHASONE; DRUG ADMINISTRATION ROUTES; GLUCOCORTICOIDS; HEARING LOSS, SUDDEN; HUMANS; MIDDLE AGED; SALVAGE THERAPY; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 81855228606     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318238fc43     Document Type: Article

References (23)

1. Flint PW, Haughey BH, Lund VJ, et al. Cummings Otolaryngology: Head & Neck Surgery. 5th ed. Philadelphia, PA: Mosby, 2010: 2117-30.
2. De Kleyn A. Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Otolaryngol (Stocckh) 1944;32:407-29.
3. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980;106:772-6. (Pubitemid 11194190)
4. Rauch SD. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med 2008;359:833-40.
5. Dallan I, De Vito A, Fattori B, et al. Intratympanic methylpredni-solone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis. Otol Neurotol 2010; 31:25-30.
6. Ahn JH, Han MW, Kim JH, Chung JW, Yoon TH. Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 2008;128:128-31
7. Niedermeyer HP, Zahneisen G, Luppa P, Busch R, Arnold W. Cortisol levels in the human perilymph after intravenous administration of prednisolone. Audiol Neurootol 2003;8:316-21. (Pubitemid 37323441)
8. Herr BD, Marzo SJ. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132:527-31. (Pubitemid 40460877)
9. Chandrasekhar SS. Intratympanic dexamethasone for sudden sen-sorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22:18-23. (Pubitemid 32182848)
10. Moon IS, Kim J, Lee SY, Choi HS, Lee WS. How long should the sudden hearing loss patients be followed after early steroid combination therapy? Eur Arch Otorhinolaryngol 2009;266:1391-5.
11. Siegel LG. The treatment ofidiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 1985;8:467-73.
12. Schreiber BE, Agrup C, Haskard DO, Luxon LM. Sudden sensor-ineural hearing loss. Lancet 2010;375:1203-11.
13. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. In-tratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3-15. (Pubitemid 46066055)
14. Lee JB, Choi SJ, Park K, Park HY, Choo OS, Choung YH. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensor-ineural hearing loss. Eur Arch Otorhinolayngol 2011;268:833-9.
15. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-80. (Pubitemid 8161819)
16. Huy PT, Sauvaget E. Idiopathic sudden sensorineural hearing loss is not an otologic emergency. Otol Neurotol 2005;26:896-902. (Pubitemid 41330704)
17. Tucci DL, Farmer JC, Kitsh RD, Witsell DL. Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol 2002;23:301-8. (Pubitemid 34506637)
18. Hong SM, Park CH, Lee JH. Hearing outcomes of daily intra-tympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg 2009;141:579-83.
19. Ahn JH, Yoo MH, Yoon TH, Chung JW. Can intratympanic dex- amethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope 2008;118:279-82 (Pubitemid 351640202)
20. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008;29:453-60.
21. Park HH, Choi JH, Huh EJ, Lee TH, Nam JK, Kwon JK. Comparison of the effect of high-dose steroid with that of super-high-dose steroid therapy in sudden sensorineural hearing loss. Korean J Otolaryngol Head Neck Surg 2009;52:566-71.
22. Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intra-tympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006; 27:564-9.
23. Hausman F, Kempton B, MacArthur C, Trune D. Enhanced inner ear ion homeostasis gene expression with intratympanic steroid delivery. ARO Abs. Mt. Royal, NJ: Association for Research in Otolaryngology 2010;33:63-4.